The tablet splitter: barrier to compliance or cost-saving instrument?

Am J Health Syst Pharm. 1995 Dec 1;52(23):2707-8. doi: 10.1093/ajhp/52.23.2707.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticholesteremic Agents / administration & dosage
  • Anticholesteremic Agents / economics
  • Anticholesteremic Agents / therapeutic use
  • Cost Savings
  • Female
  • Humans
  • Lovastatin / administration & dosage
  • Lovastatin / economics
  • Lovastatin / therapeutic use
  • Male
  • Middle Aged
  • Patient Compliance*
  • Tablets*

Substances

  • Anticholesteremic Agents
  • Tablets
  • Lovastatin